Five-year results after laparoscopic sleeve gastrectomy: a prospective study
| Autor: | Primal P. Singh, Andrew G. Hill, Habib Rahman, Andrew D. MacCormick, Daniel P. Lemanu, Richard Babor |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Subset Analysis medicine.medical_specialty Sleeve gastrectomy Time Factors medicine.medical_treatment Body Mass Index Gastrectomy Weight loss Surveys and Questionnaires Weight Loss medicine Humans Prospective Studies Prospective cohort study business.industry Middle Aged medicine.disease Obesity Morbid Surgery Obstructive sleep apnea Treatment Outcome Hemoglobin A Female Laparoscopy medicine.symptom business Body mass index Follow-Up Studies |
| Zdroj: | Surgery for Obesity and Related Diseases. 11:518-524 |
| ISSN: | 1550-7289 |
| DOI: | 10.1016/j.soard.2014.08.019 |
| Popis: | Background Whilst the early to mid-term efficacy of laparoscopic sleeve gastrectomy (SG) is well established, there is comparatively less detailing of long-term efficacy. The objectives of this study were to evaluate the long-term outcomes of patients undergoing SG at the authors' institution. Methods All patients undergoing SG during the past 5 or more years were eligible. Outcomes included baseline demographic data, preoperative characteristics, percentage excess weight loss (%EWL), co-morbidity improvement and resolution, serum hemoglobin A 1c (HbA 1c ), serum lipid profile, and the Bariatric Analysis Reporting Outcome System (BAROS) questionnaire. A subset analysis was also performed with patients stratified in to super obese (body mass index≥50 kg/m 2 ). Results There were 96 patients who underwent surgery between March 2007 and July 2008. Of these, 10 declined to participate, 28 were unable to be contacted, and 3 were deceased; therefore, 55 patients were included in the analysis. The mean yearly %EWL to postoperative year 5 was 56% (year 1), 55% (year 2), 46% (year 3), 43% (year 4), and 40% (year 5). Combined improvement and resolution rates at 5 years were 79%, 61%, and 73% for type 2 diabetes, hypertension, and obstructive sleep apnea, respectively. The HbA 1c was significantly reduced at long-term follow-up. The mean BAROS score was 3.13 (95% CI: 2.4, 3.9). Weight loss outcomes were less favorable in super obese patients. Conclusion Weight loss outcomes at 5 year follow-up were modest after SG though improvement in co-morbidity status was maintained. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|